Compare Asahi Intecc Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 11.11%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 98.37
3
Healthy long term growth as Net Sales has grown by an annual rate of 14.66%
4
The company has declared Positive results for the last 3 consecutive quarters
Stock DNA
Pharmaceuticals & Biotechnology
JPY 777,954 Million (Mid Cap)
30.00
NA
0.00%
-0.23
17.72%
5.25
Revenue and Profits:
Net Sales:
28,210 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,977 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.46%
0%
5.46%
6 Months
6.52%
0%
6.52%
1 Year
-0.24%
0%
-0.24%
2 Years
-14.64%
0%
-14.64%
3 Years
11.16%
0%
11.16%
4 Years
28.8%
0%
28.8%
5 Years
-23.07%
0%
-23.07%
Asahi Intecc Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.66%
EBIT Growth (5y)
14.04%
EBIT to Interest (avg)
98.37
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.70
Tax Ratio
38.95%
Dividend Payout Ratio
51.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.52%
ROE (avg)
11.11%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
4.15
EV to EBIT
20.72
EV to EBITDA
15.11
EV to Capital Employed
5.38
EV to Sales
4.92
PEG Ratio
0.78
Dividend Yield
NA
ROCE (Latest)
25.97%
ROE (Latest)
14.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
28,210.00
30,324.00
-6.97%
Operating Profit (PBDIT) excl Other Income
6,518.00
10,997.00
-40.73%
Interest
10.00
23.00
-56.52%
Exceptional Items
-300.00
-10,730.00
97.20%
Consolidate Net Profit
3,977.00
-3,478.00
214.35%
Operating Profit Margin (Excl OI)
154.70%
274.40%
-11.97%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.97% vs 0.06% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 214.35% vs -163.29% in Mar 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
120,025.00
107,547.00
11.60%
Operating Profit (PBDIT) excl Other Income
40,226.00
31,855.00
26.28%
Interest
214.00
226.00
-5.31%
Exceptional Items
-10,930.00
-199.00
-5,392.46%
Consolidate Net Profit
12,792.00
15,895.00
-19.52%
Operating Profit Margin (Excl OI)
250.60%
205.80%
4.48%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 11.60% vs 19.36% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is -19.52% vs 19.73% in Jun 2024
About Asahi Intecc Co., Ltd. 
Asahi Intecc Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






